Rene Quevedo, Ph.D.
Affiliations: | 2014-2020 | Medical Biophysics | University of Toronto, Toronto, ON, Canada |
Google:
"Rene Quevedo"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Boukhaled GM, Gadalla R, Elsaesser HJ, et al. (2022) Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy. Nature Immunology |
| Hezaveh K, Shinde RS, Klötgen A, et al. (2022) Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 55: 324-340.e8 |
| El Ghamrasni S, Quevedo R, Hawley J, et al. (2021) Mutations in Noncoding -Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast Cancer. Molecular Cancer Research : McR |
| Oldfield LE, Li T, Tone A, et al. (2020) An integrative DNA sequencing and methylation panel to assess mismatch repair deficiency. The Journal of Molecular Diagnostics : Jmd |
| Quevedo R, Smirnov P, Tkachuk D, et al. (2020) Assessment of Genetic Drift in Large Pharmacogenomic Studies. Cell Systems |
| Quevedo R, Spreafico A, Bruce J, et al. (2020) Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumor. Genome Medicine. 12: 38 |
| Loganathan SK, Schleicher K, Malik A, et al. (2020) Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling. Science (New York, N.Y.). 367: 1264-1269 |
| Colombo I, Garg S, Danesh A, et al. (2019) Heterogeneous alteration of the ERBB3-MYC axis associated with MEK inhibitor resistance in a -mutated low-grade serous ovarian cancer patient. Cold Spring Harbor Molecular Case Studies. 5 |
| Yang SYC, Lheureux S, Karakasis K, et al. (2018) Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors. Genome Medicine. 10: 81 |
| Lheureux S, Bruce JP, Burnier JV, et al. (2017) Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016713677 |